Today's Top Stories | | By Chris Markoch | July 31, 2026 11:45 AM |
| | | By Peter Frank | July 31, 2026 10:00 AM |
| | By Jeffrey Neal Johnson | July 31, 2026 09:25 AM |
| | | By Nathan Reiff | July 31, 2026 06:30 AM |
| | By Chris Markoch | July 30, 2026 07:35 AM |
|
|
 | This could help save your retirement (Ad)Murray Stahl is a Wall Street money manager who put more than half of his $9 billion firm into a single stock - one that returned 46,950% between 2002 and 2026, according to Morningstar.
Whitney Tilson of Stansberry Research believes this company, which sits at the center of AI and another major U.S. industry, could be a rare retirement-building opportunity. He's revealing the name and ticker for free.
Get the name and stock symbol at no charge |
|
Analysts' Upgrades | | AXT (NASDAQ:AXTI) was upgraded by Needham & Company LLC from "hold" to "buy". They now have a $90.00 price target on the stock. This represents a 48.9% upside from the current price of $60.43. | | Baxter International (NYSE:BAX) was upgraded by Citigroup Inc. from "sell" to "neutral". They now have a $28.00 price target on the stock, up from $17.00. This represents a 6.9% upside from the current price of $26.20. | | Eldorado Gold (NYSE:EGO) (TSE:ELD) was upgraded by Stifel Nicolaus from "hold" to "buy". The current price is $30.27. | | Essex Property Trust (NYSE:ESS) was upgraded by Citizens Jmp from "market perform" to "outperform". They now have a $330.00 price target on the stock. This represents a 15.9% upside from the current price of $284.68. | | Ford Motor (NYSE:F) was upgraded by DZ Bank AG from "sell" to "hold". They now have a $16.00 price target on the stock. This represents a 8.9% upside from the current price of $14.70. | | Huntington Ingalls Industries (NYSE:HII) was upgraded by Wolfe Research from "peer perform" to "outperform". They now have a $364.00 price target on the stock. This represents a 11.2% upside from the current price of $327.24. | | Patterson-UTI Energy (NASDAQ:PTEN) was upgraded by JPMorgan Chase & Co. from "underweight" to "neutral". They now have a $12.00 price target on the stock. This represents a 14.5% upside from the current price of $10.48. | | Plexus (NASDAQ:PLXS) was upgraded by Sidoti from "neutral" to "buy". They now have a $308.00 price target on the stock. This represents a 22.5% upside from the current price of $251.34. | | Quanta Services (NYSE:PWR) was upgraded by Guggenheim from "neutral" to "buy". They now have a $800.00 price target on the stock. This represents a 19.8% upside from the current price of $667.83. | | Saia (NASDAQ:SAIA) was upgraded by Stifel Nicolaus from "hold" to "buy". They now have a $438.00 price target on the stock. This represents a 26.0% upside from the current price of $347.63. |
|
View More Upgrades
|
Analysts' Downgrades | | Coastal Financial (NASDAQ:CCB) was downgraded by Raymond James Financial, Inc. from "strong-buy" to "outperform". They now have a $50.00 price target on the stock. This represents a 22.0% upside from the current price of $40.99. | | Enbridge (NYSE:ENB) (TSE:ENB) was downgraded by Raymond James Financial, Inc. from "outperform" to "market perform". The current price is $54.40. | | GoDaddy (NYSE:GDDY) was downgraded by Raymond James Financial, Inc. from "strong-buy" to "outperform". They now have a $100.00 price target on the stock. This represents a 20.8% upside from the current price of $82.79. | | Group 1 Automotive (NYSE:GPI) was downgraded by JPMorgan Chase & Co. from "overweight" to "neutral". They now have a $320.00 price target on the stock, down from $380.00. This represents a 11.4% upside from the current price of $287.18. | | Karyopharm Therapeutics (NASDAQ:KPTI) was downgraded by Robert W. Baird from "outperform" to "neutral". They now have a $3.00 price target on the stock. This represents a 56.3% upside from the current price of $1.92. |
|
View More Downgrades
|
Analysts' New Coverage | | 4D Molecular Therapeutics (NASDAQ:FDMT) is now covered by B. Riley Financial, Inc.. They set a "buy" rating and a $37.00 price target on the stock. This represents a 263.5% upside from the current price of $10.18. | | Freddie Mac (OTCMKTS:FMCC) is now covered by Wedbush. They set an "outperform" rating and a $12.00 price target on the stock. This represents a 117.9% upside from the current price of $5.51. | | Sensei Biotherapeutics (NASDAQ:FTH) is now covered by Raymond James Financial, Inc.. They set an "outperform" rating and a $56.00 price target on the stock. This represents a 105.6% upside from the current price of $27.24. |
|
View More New Coverage
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
|
